Loss of zolpidem efficacy in the hippocampus of mice with the GABAA receptor gamma2 F77I point mutation.
Zolpidem is a hypnotic benzodiazepine site agonist with some gamma-aminobutyric acid (GABA)(A) receptor subtype selectivity. Here, we have tested the effects of zolpidem on the hippocampus of gamma2 subunit (gamma2F77I) point mutant mice. Analysis of forebrain GABA(A) receptor expression with immuno...
Auteurs principaux: | Cope, D, Halbsguth, C, Karayannis, T, Wulff, P, Ferraguti, F, Hoeger, H, Leppä, E, Linden, A, Oberto, A, Ogris, W, Korpi, E, Sieghart, W, Somogyi, P, Wisden, W, Capogna, M |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2005
|
Documents similaires
-
Abolition of zolpidem sensitivity in mice with a point mutation in the GABAA receptor gamma2 subunit.
par: Cope, D, et autres
Publié: (2004) -
Increased motor-impairing effects of the neuroactive steroid pregnanolone in mice with targeted inactivation of the GABAA receptor gamma2 subunit in the cerebellum
par: Elli Leppä, et autres
Publié: (2016-10-01) -
Ro 15-4513 antagonizes alcohol-induced sedation in mice through alpha-beta-gamma2-type GABAA receptors
par: Anni-Maija eLinden, et autres
Publié: (2011-01-01) -
The effect of zolpidem, a GABAA-receptor agonist, on human motor learning and TMS metrics
par: Ioana Grigoras, et autres
Publié: (2023-01-01) -
Expression of COUP-TFII nuclear receptor in restricted GABAergic neuronal populations in the adult rat hippocampus.
par: Fuentealba, P, et autres
Publié: (2010)